![](https://ipaccessmeds.southcentre.int/wp-content/uploads/2024/07/wipo-building-400x400.jpeg)
South Centre Statement to the Sixty-Fifth Series of Meetings of the Assemblies of the Member States of WIPO (2024)
10 July 2024
10 July 2024
![](https://ipaccessmeds.southcentre.int/wp-content/uploads/2024/05/20240527_WHA77_plenary_PAL_1014_013-400x400.jpg)
STATEMENT BY CARLOS CORREA, EXECUTIVE DIRECTOR OF THE SOUTH CENTRE, AT THE VIRTUAL MEETING OF THE MINISTERS OF HEALTH OF THE MEMBER STATES AND OBSERVER STATES OF THE NON-ALIGNED MOVEMENT
25 May 2024, on the sidelines of the 77th session of the World Health Assembly
25 May 2024, on the sidelines of the 77th session of the World Health Assembly
![](https://ipaccessmeds.southcentre.int/wp-content/uploads/2023/10/pexels-cottonbro-studio-3923175-400x400.jpg)
Colombia declara de interés público el uso de patente sobre Dolutegravir para incrementar el acceso a tratamiento a personas que viven con HIV
3 de octubre de 2023
South Centre Statement
3 de octubre de 2023
South Centre Statement
![](https://ipaccessmeds.southcentre.int/wp-content/uploads/2023/09/d31ec30e-2712-4887-8deb-fb500feeba7a-400x400.jpeg)
South Centre Statement to the High Level Meeting on Pandemic Prevention, Preparedness and Response
20 September 2023
20 September 2023
![](https://ipaccessmeds.southcentre.int/wp-content/uploads/2023/05/UNGA-Pandemic-400x400.jpg)
Summary of the intervention by Carlos Correa, Executive Director of the South Centre, at the UN General Assembly – Pandemic Prevention, Preparedness and Response Multi-Stakeholder Hearing
New York, May 9th, 2023
New York, May 9th, 2023
![](https://ipaccessmeds.southcentre.int/wp-content/uploads/2023/01/pexels-anna-shvets-3786157-1024x683-1-400x400.jpeg)
South Centre Statement on the extension of the TRIPS waiver for diagnostics and therapeutics for COVID-19
Extension de la dérogation d’une partie de l’Accord ADPIC aux traitements et outils de diagnostic de la COVID-19
Declaración sobre la extensión de la exención del ADPIC para diagnósticos y terapias para COVID-19
9 January 2023/9 janvier 2023/9 de enero de 2023
Extension de la dérogation d’une partie de l’Accord ADPIC aux traitements et outils de diagnostic de la COVID-19
Declaración sobre la extensión de la exención del ADPIC para diagnósticos y terapias para COVID-19
9 January 2023/9 janvier 2023/9 de enero de 2023
![](https://ipaccessmeds.southcentre.int/wp-content/uploads/2022/12/who-wipo-wto-400x400.png)
WHO, WIPO & WTO Trilateral Symposium 2022 South Centre Opening Statement
16 December 2022
by Viviana Munoz Tellez
16 December 2022
by Viviana Munoz Tellez
![](https://ipaccessmeds.southcentre.int/wp-content/uploads/2018/12/SC-IP-Meds_Services_BG-600x600.jpg)
Statement by the South Centre on the WTO Doha Ministerial Declaration on TRIPS and Public Health on its Twentieth Anniversary
November 2021
November 2021
![](https://ipaccessmeds.southcentre.int/wp-content/uploads/2021/09/pexels-august-de-richelieu-4427931-400x400.jpg)
Statement by the South Centre on the extension of the transition period for LDCs under the TRIPS Agreement
30 June 2021
30 June 2021
![](https://ipaccessmeds.southcentre.int/wp-content/uploads/2021/09/pexels-pixabay-356040-400x400.jpg)
South Centre Statement for Nam Health Ministers Meeting at the 74th World Health Assembly
27 May 2021
27 May 2021